Date | EBITDA Margin | EBIT Margin | Depreciation and Amortization | EBIT |
---|
CEO | Dr. Jason Kelly Ph.D. |
IPO Date | April 19, 2021 |
Location | United States |
Headquarters | 27 Drydock Avenue |
Employees | 1,218 |
Sector | Health Care |
Industries |
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email